ACAD
41.88
+2.02
+5.07%
AEMD
6.51
-0.04
-0.61%
APRI
1.71
+0.04
+2.40%
ARNA
4.64
+0.34
+7.91%
ATEC
1.38
0.00
0.00%
CNAT
5.15
+0.04
+0.78%
CRXM
0.36
-0.02
-4.53%
CYTX
0.557
-0.003
-0.536%
DXCM
79.98
+0.88
+1.11%
GNMK
9.06
-0.04
-0.44%
HALO
22.58
+1.34
+6.31%
ILMN
218.36
+4.38
+2.05%
INNV
0.12
0.00
+3.00%
INO
8.16
+0.17
+2.13%
ISCO
0.043
+0.002
+5.1220%
ISIS
57.55
+1.5
+2.68%
LGND
100.9
+4.1
+4.24%
LPTN
0.276
+0.016
+6.236%
MBVX
2.32
-0.01
-0.43%
MEIP
1.71
+0.01
+0.59%
MNOV
3.95
-0.02
-0.50%
MRTX
31.47
+0.61
+1.98%
MSTX
0.49
+0.02
+4.30%
NBIX
47.76
+1.95
+4.26%
NUVA
47.38
-0.22
-0.46%
ONCS
6.33
-0.09
-1.40%
ONVO
3.77
+0.12
+3.29%
OREX
4.95
+0.41
+9.03%
OTIC
22.99
+1.89
+8.96%
QDEL
22.95
+0.1
+0.44%
RCPT
190.05
+14.05
+7.98%
RGLS
10.96
+0.85
+8.41%
RMD
56.37
+0.93
+1.68%
SCIE
0.018
-0.001
-3.8251%
SPHS
0.785
-0.025
-3.1111%
SRNE
17.62
+1.05
+6.34%
TROV
10.15
+0.92
+9.97%
VICL
0.7
0.00
0.00%
ZGNX
1.68
+0.06
+3.70%
ACAD
41.88
+2.02
+5.07%
AEMD
6.51
-0.04
-0.61%
APRI
1.71
+0.04
+2.40%
ARNA
4.64
+0.34
+7.91%
ATEC
1.38
0.00
0.00%
CNAT
5.15
+0.04
+0.78%
CRXM
0.36
-0.02
-4.53%
CYTX
0.557
-0.003
-0.536%
DXCM
79.98
+0.88
+1.11%
GNMK
9.06
-0.04
-0.44%
HALO
22.58
+1.34
+6.31%
ILMN
218.36
+4.38
+2.05%
INNV
0.12
0.00
+3.00%
INO
8.16
+0.17
+2.13%
ISCO
0.043
+0.002
+5.1220%
ISIS
57.55
+1.5
+2.68%
LGND
100.9
+4.1
+4.24%
LPTN
0.276
+0.016
+6.236%
MBVX
2.32
-0.01
-0.43%
MEIP
1.71
+0.01
+0.59%
MNOV
3.95
-0.02
-0.50%
MRTX
31.47
+0.61
+1.98%
MSTX
0.49
+0.02
+4.30%
NBIX
47.76
+1.95
+4.26%
NUVA
47.38
-0.22
-0.46%
ONCS
6.33
-0.09
-1.40%
ONVO
3.77
+0.12
+3.29%
OREX
4.95
+0.41
+9.03%
OTIC
22.99
+1.89
+8.96%
QDEL
22.95
+0.1
+0.44%
RCPT
190.05
+14.05
+7.98%
RGLS
10.96
+0.85
+8.41%
RMD
56.37
+0.93
+1.68%
SCIE
0.018
-0.001
-3.8251%
SPHS
0.785
-0.025
-3.1111%
SRNE
17.62
+1.05
+6.34%
TROV
10.15
+0.92
+9.97%
VICL
0.7
0.00
0.00%
ZGNX
1.68
+0.06
+3.70%
Home » Archive by Category

Diagnostics

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

The Future of Personal Genetic Testing and Diagnostics with Pathway Genomics

August 26, 2011 – 9:57 am

The Pathway Genomics business model is based on bridging a gap in personalized medicine.  As Ed MacBean, their VP of Product Development, explained at SDBN’s August 16th event, in a nutshell they connect clients through …

SDBN August 16th 2011 Event Featuring Pathway Genomics

July 29, 2011 – 9:41 am

We polled you late last year about events you’d like us to have in 2011, and diagnostics was one of the top items on the list. In San Diego, we have a great atmosphere for …